Growing from 0 to 1 to ∞

The capabilities you require to grow an idea into a viable product and very different from the capabilities required to grow that product into a large scale business. Join us to discuss open innovation approaches to growing scalable businesses by leveraging the strengths of startups and corporates.

About this event

The capabilities you require to grow an idea into a viable product and very different from the capabilities required to grow that product into a large scale business. Join us to discuss open innovation approaches to growing scalable businesses by leveraging the strengths of startups and corporates. We will also explore the equally important question of how startups can access corporate resources to achieve scale. Key questions that every entrepreneur or intrapreneur must answer:

- How do we validate that a novel idea is actually valuable before pouring time and money into it? 

- If we prove that the idea is valuable, how do we pull together the talent we need to build the solution? 

- Once we build it, how do we scale it fast, before a hundred competitors enter the market?

There are certain things that startups do well, like finding crazy brilliant solutions and identifying trends before they are visible to corporate strategy teams. And there are certain things that corporates do well, like pumping a new solution through giant market channels that have been build over decades to quickly gain market share. Nobody is good at everything so in this session we will explore how to grow future market-leading businesses by working together. 

We will be joined by the head of BI X, Boehringer Ingelheim's innovation team, the head of open innovation at Siemens Healthineers, and an as-yet undisclosed startup to explore how they work with startups to build new businesses. Boehringer Ingelheim is one of the world's largest pharmaceutical companies, with revenues of €19 billion. The evolved from a baking soda manufacturer in 1885 into a leader in respiratory diseases, immunology, and diseases of the central nervous system. Siemens Healthineers is a leading medical technology company with revenues of €15 billion.

When

Thursday, Jul 29
6:30 PM - 9:30 PM (CST)

Where

Park Place (41F)
Park Place, 1601 West Nanjing Road Shanghai2000004

Brought to you by

  • Erik Walenza-Slabe

    Erik Walenza-Slabe

    IoT ONE

    Shanghai Director

    View Profile
  • Rebecca Liang

    Rebecca Liang

    Co-Director

    View Profile
  • Mia Sun

    Mia Sun

    Team Member

    View Profile
  • Tatia Chao

    Tatia Chao

    Team Member

    View Profile
  • Marian Danko

    Marian Danko

    weHustle

    Team Member

    View Profile
  • Yunfei Ma

    Yunfei Ma

    IoT One

    Team Member

  • Liya Shi

    Liya Shi

    Team Member

  • Sihao Kuo

    Team Member

  • Diwei Chen

    Team Member

  • Sunny Ting

    Sunny Ting

    BI X (a part of Boehringer Ingelheim)

    Co-Director

    View Profile

Partners